Knowles Reports Q2 2024 Financial Results and Provides Outlook for Q3 2024
Knowles (NYSE: KN) reported Q2 2024 financial results, with revenues increasing 18% year-over-year to $205M, in line with guidance. The company generated $25 million in net cash from operations. Knowles expects sequential and year-over-year revenue growth in Q3 2024 for its Medtech and Specialty Audio and Precision Devices segments, along with sequential earnings growth and strong cash generation.
Key financial highlights include:
- Q2 2024 revenues: $204.7M
- Non-GAAP gross profit: $79.7M (38.9% of revenues)
- Non-GAAP diluted earnings per share: $0.24
- Net cash provided by operating activities: $24.9M
The company's transition to higher value markets and products is progressing well, with improving demand across several end markets within the Precision Devices segment.
Knowles (NYSE: KN) ha riportato i risultati finanziari del secondo trimestre 2024, con entrate in aumento del 18% anno su anno, raggiungendo i 205 milioni di dollari, in linea con le previsioni. L'azienda ha generato 25 milioni di dollari di cassa netta dalle operazioni. Knowles prevede una crescita sequenziale e anno su anno delle entrate nel terzo trimestre 2024 per i suoi segmenti Medtech, Audio Speciale e Dispositivi di Precisione, insieme a una crescita sequenziale degli utili e a una forte generazione di cassa.
I principali punti finanziari includono:
- Entrate Q2 2024: 204,7 milioni di dollari
- Utili lordi Non-GAAP: 79,7 milioni di dollari (38,9% delle entrate)
- Utili per azione diluiti Non-GAAP: 0,24 dollari
- Cassa netta fornita dalle attività operative: 24,9 milioni di dollari
La transizione dell'azienda verso mercati e prodotti di maggiore valore sta progredendo bene, con una domanda in aumento in diversi mercati finali all'interno del segmento Dispositivi di Precisione.
Knowles (NYSE: KN) reportó los resultados financieros del segundo trimestre de 2024, con ingresos incrementando un 18% interanual, alcanzando los 205 millones de dólares, en línea con la guía. La compañía generó 25 millones de dólares en efectivo neto de las operaciones. Knowles espera crecimiento de ingresos secuencial y año tras año en el tercer trimestre de 2024 para sus segmentos de Medtech, Audio Especial y Dispositivos de Precisión, junto con crecimiento de ganancias secuencial y una fuerte generación de efectivo.
Los aspectos financieros clave incluyen:
- Ingresos Q2 2024: 204.7 millones de dólares
- Beneficio bruto No-GAAP: 79.7 millones de dólares (38.9% de los ingresos)
- Ganancias por acción diluidas No-GAAP: 0.24 dólares
- Efectivo neto proporcionado por actividades operativas: 24.9 millones de dólares
La transición de la compañía hacia mercados y productos de mayor valor está progresando bien, con una demanda creciente en varios mercados finales dentro del segmento de Dispositivos de Precisión.
Knowles (NYSE: KN)은 2024년 2분기 재무 결과를 발표했습니다. 매출이 전년 대비 18% 증가하여 2억 5천만 달러에 달했습니다, 이는 예측과 일치합니다. 이 회사는 운영 활동에서 2천5백만 달러의 순현금을 생성했습니다. Knowles는 2024년 3분기 Medtech, 전문 오디오 및 정밀 장치 부문에서 sequential 및 전년 대비 매출 성장을 예상하며, 수익성 또한 sequential 성장과 강력한 현금 생성이 이어질 것으로 기대하고 있습니다.
주요 재무 하이라이트는 다음과 같습니다:
- 2024년 2분기 매출: 2억 4천만 달러
- 비-GAAP 총 이익: 7천9백7십만 달러 (매출의 38.9%)
- 비-GAAP 희석주당 순이익: 0.24달러
- 운영 활동에 의해 제공된 순현금: 2천4십만 달러
회사는 고부가가치 시장 및 제품으로의 전환이 잘 진행되고 있으며, 정밀 장치 부문 내 여러 최종 시장에서 수요가 증가하고 있습니다.
Knowles (NYSE: KN) a annoncé les résultats financiers du deuxième trimestre 2024, avec des revenus augmentant de 18% par rapport à l'année précédente, atteignant 205 millions de dollars, conformément aux prévisions. L'entreprise a généré 25 millions de dollars de cash net provenant des opérations. Knowles s'attend à une croissance séquentielle et d'une année sur l'autre des revenus au troisième trimestre 2024 pour ses segments Medtech, Audio Spécial et Dispositifs de Précision, ainsi qu'à une croissance séquentielle des bénéfices et une forte génération de cash.
Les principaux faits marquants financiers comprennent :
- Revenus Q2 2024 : 204,7 millions de dollars
- Bénéfice brut Non-GAAP : 79,7 millions de dollars (38,9% des revenus)
- Bénéfice par action dilué Non-GAAP : 0,24 dollar
- Cash net fourni par les activités d'exploitation : 24,9 millions de dollars
La transition de l'entreprise vers des marchés et des produits de plus grande valeur progresse bien, avec une demande croissante dans plusieurs marchés finaux au sein du segment des Dispositifs de Précision.
Knowles (NYSE: KN) hat die Finanzzahlen für das zweite Quartal 2024 veröffentlicht, mit Umsätzen, die im Jahresvergleich um 18% auf 205 Millionen Dollar gestiegen sind, was im Einklang mit den Prognosen steht. Das Unternehmen erzielte 25 Millionen Dollar netto durch Betriebstätigkeiten. Knowles erwartet eine sequenzielle und jahresvergleichende Umsatzsteigerung im dritten Quartal 2024 für seine Medtech-, Spezialaudio- und Präzisionsgerätesegmente, sowie sequenzielle Gewinnsteigerung und starke Cash-Generierung.
Wichtige finanzielle Highlights sind:
- Umsatz Q2 2024: 204,7 Millionen Dollar
- Non-GAAP Bruttogewinn: 79,7 Millionen Dollar (38,9% der Umsätze)
- Non-GAAP verwässerter Gewinn pro Aktie: 0,24 Dollar
- Netto-Cash aus Betriebstätigkeiten: 24,9 Millionen Dollar
Der Übergang des Unternehmens zu Märkten und Produkten mit höherem Wert verläuft gut, mit einer steigenden Nachfrage in mehreren Endmärkten innerhalb des Präzisionsgerätesegments.
- Revenue increased 18% year-over-year to $205M in Q2 2024
- Strong cash generation with $25M net cash from operations
- Non-GAAP diluted earnings per share of $0.24, up from $0.20 in Q1 2024
- Expecting sequential and year-over-year revenue growth in Q3 2024 for key segments
- Improving demand across several end markets in the Precision Devices segment
- GAAP diluted loss per share of $2.90 in Q2 2024
- Goodwill impairment charge of $2.77 per share for Consumer MEMS Microphones reporting unit
- Gross profit margin decreased from 42.6% in Q2 2023 to 37.9% in Q2 2024
Insights
Knowles 's Q2 2024 results present a mixed picture. While revenue growth of
The GAAP gross profit margin decreased significantly from
The most alarming figure is the GAAP diluted loss per share of
On a positive note, cash flow generation remains strong with
Looking ahead, management's outlook for Q3 2024 indicates sequential and year-over-year growth in key segments. However, investors should closely monitor margin trends and the performance of the Consumer MEMS Microphones unit in upcoming quarters.
Knowles' Q2 results and Q3 outlook provide interesting insights into the dynamics of the high-performance electronics market. The
The company's transition towards higher-value markets and products is a strategic move that could potentially enhance long-term shareholder value. This shift is particularly evident in the expected growth of the Medtech and Specialty Audio segments.
However, the significant goodwill impairment in the Consumer MEMS Microphones unit raises questions about the consumer electronics market's health. This could be indicative of broader challenges in this sector, possibly due to market saturation or increased competition.
The anticipated improvement in demand across several end markets within the Precision Devices segment is a positive sign. This could be reflective of a broader recovery in industrial and automotive sectors, which are key consumers of high-performance electronic components.
Investors should keep an eye on how Knowles navigates the evolving market landscape, particularly its ability to capitalize on growth opportunities in medtech and precision devices while managing challenges in consumer electronics. The company's success in this transition will be important for its future performance and market positioning.
Second Quarter Revenues increased
Net Cash from Operations of
“We closed the second quarter of 2024 with revenues, Non-GAAP diluted earnings per share, and net cash from operating activities in line with our expectations and at the mid-point of our guided range. Our revenues grew from the prior year by
“Building upon our second quarter performance, in the third quarter we expect sequential and year over year revenue growth in our Medtech and Specialty Audio and Precision Devices segments, along with sequential earnings growth and sustained strong cash generation.”
Mr. Niew added, “I am pleased with our execution in transitioning our company's portfolio to higher value markets and products to drive shareholder value. As we begin to see demand improve across several end markets within the Precision Devices segment, we believe we are well positioned for future growth."
Financial Highlights
The following table highlights the Company’s financial performance on both a GAAP and supplemental non-GAAP basis (in millions, except per share data):
|
Q2-24 |
Q1-24 |
Q2-23 |
Revenues |
|
|
|
Gross profit |
|
|
|
(as a % of revenues) |
|
|
|
Non-GAAP gross profit |
|
|
|
(as a % of revenues) |
|
|
|
Diluted (loss) earnings per share* |
|
|
|
Non-GAAP diluted earnings per share |
|
|
|
Net cash provided by operating activities |
|
|
|
* Current period results include
Third Quarter 2024 Outlook
The forward looking guidance for the quarter ending September 30, 2024 is as follows:
|
GAAP |
Adjustments |
Non-GAAP |
Revenues |
|
— |
|
Diluted earnings per share |
|
|
|
Net cash provided by operating activities |
|
— |
|
Q3 2024 GAAP results are expected to include approximately
Non-GAAP Financial Measures
In addition to the GAAP results included in this press release, Knowles has presented supplemental non-GAAP gross profit, earnings before interest and income taxes, adjusted earnings before interest and income taxes, non-GAAP diluted earnings per share, free cash flow, as well as other metrics on a non-GAAP basis that exclude certain amounts that are included in the most directly comparable GAAP measure to facilitate evaluation of Knowles’ operating performance. Non-GAAP results are not presented in accordance with GAAP. Non-GAAP information should be considered a supplement to, and not a substitute for, financial statements prepared in accordance with GAAP. In addition, the non-GAAP financial measures included in this press release do not have standard meanings and may vary from similarly titled non-GAAP financial measures used by other companies. Knowles believes that non-GAAP measures are useful as supplements to its GAAP results of operations to evaluate certain aspects of its operations and financial performance, and its management team primarily focuses on non-GAAP items in evaluating Knowles’ performance for business planning purposes. Knowles also believes that these measures assist it with comparing its performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in Knowles’ opinion, do not reflect its core operating performance including, for example, stock-based compensation, certain intangibles amortization expense, impairment charges, restructuring, production transfer costs, and other charges which management considers to be outside our core operating results. Knowles believes that its presentation of these non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that Knowles uses internally for purposes of assessing its core operating performance. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, see the reconciliation table accompanying this release.
Webcast and Conference Call Information
Investors can listen to a live or replay webcast of the Company’s quarterly financial conference call at http://investor.knowles.com. The live webcast will begin today at 3:30 p.m. Central time. The webcast replay will be available after 7:00 p.m. Central time today.
A conference call replay will be available after 7:00 p.m. Central time on July 31 through 11:59 p.m. Central time on August 8 at (800) 770-2030 (Toll-Free Dial-In); (609) 800-9909 (Toll Dial-In). The conference ID is 3966457. A webcast replay will also be accessible via the Knowles website at http://investor.knowles.com for a limited time.
About Knowles
Knowles is a market leader and global provider of high performance capacitors and radio frequency ("RF") filtering products, and advanced micro-acoustic microphones and balanced armature speakers, audio solutions, serving the medtech, defense, consumer electronics, electric vehicle, industrial, and communications markets. Knowles' focus on the customer, combined with unique technology, proprietary manufacturing techniques, and global operational expertise, enables us to deliver innovative solutions across multiple applications. Founded in 1946 and headquartered in
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, such as statements about our future plans, objectives, expectations, financial performance, and continued business operations. The words “believe,” “expect,” “anticipate,” “project,” “estimate,” “budget,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “seek,” “should,” “will,” “would,” “objective,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” and similar expressions, among others, generally identify forward-looking statements, which speak only as of the date the statements were made. The statements in this news release are based on currently available information and the current expectations, forecasts, and assumptions of Knowles’ management concerning risks and uncertainties that could cause actual outcomes or results to differ materially from those outcomes or results that are projected, anticipated, or implied in these statements. Other risks and uncertainties include, but are not limited to: incurrence of additional impairment charges and a significant charge to earnings due to future events or factors, such as the impairment charge incurred in connection with our strategic alternatives review of the CMM segment (which could result in either a sale or a restructuring of our CMM segment), or changes to the underlying assumptions used to calculate fair value; a significant reduction in MEMS microphone sales due to any weakening demand, loss of market share, or other factors adversely affecting our levels and the timing of our sale of the MEMS microphones; our ongoing ability to execute our strategy to diversify our end markets and customers; our ability to stem or overcome price erosion in our segments; difficulties or delays in and/or the Company’s inability to realize expected synergies from its acquisitions; fluctuations in our stock's market price; fluctuations in operating results and cash flows; our ability to prevent or identify quality issues in our products or to promptly remedy any such issues that are identified; the timing of OEM product launches; risks associated with increasing our inventories in advance of anticipated orders by customers; global economic instability, including due to inflation, rising interest rates, negative impacts caused by pandemics and public health crises, or the impacts of geopolitical uncertainties; the impact of changes to laws and regulations that affect the Company’s ability to offer products or services to customers in different regions; our ability to achieve reductions in our operating expenses; the ability to qualify our products and facilities with customers; our ability to obtain, enforce, defend or monetize our intellectual property rights; disruption caused by a cybersecurity incident, including a cyber attack, cyber breach, theft, or other unauthorized access; increases in the costs of critical raw materials and components; availability of raw materials and components; managing new product ramps and introductions for our customers; our dependence on a limited number of large customers; our ability to maintain and expand our existing relationships with leading OEMs in order to maintain and increase our revenue; increasing competition and new entrants in the market for our products; our ability to develop new or enhanced products or technologies in a timely manner that achieve market acceptance; our reliance on third parties to manufacture, assemble, and test our products and sub-components; escalating international trade tensions, new or increased tariffs and trade wars among countries; financial risks, including risks relating to currency fluctuations, credit risks and fluctuations in the market value of the Company; a sustained decline in our stock price and market capitalization may result in the impairment of certain intangible or long-lived assets; market risk associated with fluctuations in commodity prices, particularly for various precious metals used in our manufacturing operation, changes in tax laws, changes in tax rates and exposure to additional tax liabilities; and other risks, relevant factors, and uncertainties identified in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, subsequent Reports on Forms 10-Q and 8-K and our other filings we make with the
INVESTOR SUPPLEMENT - SECOND QUARTER 2024 |
|||||||||||
|
|||||||||||
KNOWLES CORPORATION |
|||||||||||
CONSOLIDATED STATEMENTS OF EARNINGS |
|||||||||||
(in millions, except per share amounts) |
|||||||||||
(unaudited) |
|||||||||||
|
Quarter Ended |
||||||||||
June 30,
|
|
March 31,
|
|
June 30,
|
|||||||
Revenues |
$ |
204.7 |
|
|
$ |
196.4 |
|
|
$ |
173.0 |
|
Cost of goods sold |
|
127.9 |
|
|
|
125.5 |
|
|
|
105.8 |
|
Gain on sale of fixed assets |
|
(1.1 |
) |
|
|
— |
|
|
|
(4.8 |
) |
Restructuring charges - cost of goods sold |
|
0.3 |
|
|
|
1.0 |
|
|
|
(1.7 |
) |
Gross profit |
|
77.6 |
|
|
|
69.9 |
|
|
|
73.7 |
|
Research and development expenses |
|
20.9 |
|
|
|
20.6 |
|
|
|
19.7 |
|
Selling and administrative expenses |
|
43.0 |
|
|
|
43.5 |
|
|
|
36.5 |
|
Goodwill impairment |
|
249.4 |
|
|
|
— |
|
|
|
— |
|
Restructuring charges |
|
(0.1 |
) |
|
|
1.5 |
|
|
|
0.6 |
|
Operating expenses |
|
313.2 |
|
|
|
65.6 |
|
|
|
56.8 |
|
Operating (loss) earnings |
|
(235.6 |
) |
|
|
4.3 |
|
|
|
16.9 |
|
Interest expense, net |
|
4.6 |
|
|
|
4.4 |
|
|
|
0.8 |
|
Other expense (income), net |
|
0.3 |
|
|
|
(0.4 |
) |
|
|
(1.3 |
) |
Gain on sale of asset, net |
|
— |
|
|
|
(5.4 |
) |
|
|
— |
|
(Loss) earnings before income taxes |
|
(240.5 |
) |
|
|
5.7 |
|
|
|
17.4 |
|
Provision for income taxes |
|
18.8 |
|
|
|
3.2 |
|
|
|
3.8 |
|
Net (loss) earnings |
$ |
(259.3 |
) |
|
$ |
2.5 |
|
|
$ |
13.6 |
|
|
|
|
|
|
|
||||||
Net (loss) earnings per share: |
|
|
|
|
|
||||||
Basic |
$ |
(2.90 |
) |
|
$ |
0.03 |
|
|
$ |
0.15 |
|
Diluted |
$ |
(2.90 |
) |
|
$ |
0.03 |
|
|
$ |
0.15 |
|
|
|
|
|
|
|
||||||
Weighted-average common shares outstanding: |
|
|
|
|
|
||||||
Basic |
|
89.4 |
|
|
|
89.6 |
|
|
|
91.4 |
|
Diluted |
|
89.4 |
|
|
|
90.5 |
|
|
|
91.8 |
|
KNOWLES CORPORATION |
|||||||
CONSOLIDATED STATEMENTS OF EARNINGS |
|||||||
(in millions, except per share amounts) |
|||||||
(unaudited) |
|||||||
|
Six Months Ended |
||||||
June 30,
|
|
June 30,
|
|||||
Revenues |
$ |
401.1 |
|
|
$ |
317.3 |
|
Cost of goods sold |
|
253.4 |
|
|
|
196.2 |
|
Gain on sale of fixed assets |
|
(1.1 |
) |
|
|
(4.8 |
) |
Restructuring charges - cost of goods sold |
|
1.3 |
|
|
|
(1.6 |
) |
Gross profit |
|
147.5 |
|
|
|
127.5 |
|
Research and development expenses |
|
41.5 |
|
|
|
39.7 |
|
Selling and administrative expenses |
|
86.5 |
|
|
|
70.3 |
|
Goodwill impairment |
|
249.4 |
|
|
|
— |
|
Restructuring charges |
|
1.4 |
|
|
|
1.6 |
|
Operating expenses |
|
378.8 |
|
|
|
111.6 |
|
Operating (loss) earnings |
|
(231.3 |
) |
|
|
15.9 |
|
Interest expense, net |
|
9.0 |
|
|
|
1.6 |
|
Other (income) expense, net |
|
(0.1 |
) |
|
|
1.0 |
|
Gain on sale of asset, net |
|
(5.4 |
) |
|
|
— |
|
(Loss) earnings before income taxes |
|
(234.8 |
) |
|
|
13.3 |
|
Provision for income taxes |
|
22.0 |
|
|
|
4.9 |
|
Net (loss) earnings |
$ |
(256.8 |
) |
|
$ |
8.4 |
|
|
|
|
|
||||
Net (loss) earnings per share: |
|
|
|
||||
Basic |
$ |
(2.87 |
) |
|
$ |
0.09 |
|
Diluted |
$ |
(2.87 |
) |
|
$ |
0.09 |
|
|
|
|
|
||||
Weighted-average common shares outstanding: |
|
|
|
||||
Basic |
|
89.5 |
|
|
|
91.4 |
|
Diluted |
|
89.5 |
|
|
|
92.1 |
|
KNOWLES CORPORATION |
|||||||||||||||||||
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (1) |
|||||||||||||||||||
(in millions, except per share amounts) |
|||||||||||||||||||
(unaudited) |
|||||||||||||||||||
|
Quarter Ended |
|
Six Months Ended |
||||||||||||||||
|
June 30,
|
|
March 31,
|
|
June 30,
|
|
June 30,
|
|
June 30,
|
||||||||||
Gross profit |
$ |
77.6 |
|
|
$ |
69.9 |
|
|
$ |
73.7 |
|
|
$ |
147.5 |
|
|
$ |
127.5 |
|
Gross profit as % of revenues |
|
37.9 |
% |
|
|
35.6 |
% |
|
|
42.6 |
% |
|
|
36.8 |
% |
|
|
40.2 |
% |
Stock-based compensation expense |
|
0.5 |
|
|
|
0.5 |
|
|
|
0.7 |
|
|
|
1.0 |
|
|
|
1.2 |
|
Restructuring charges |
|
0.3 |
|
|
|
1.0 |
|
|
|
(1.7 |
) |
|
|
1.3 |
|
|
|
(1.6 |
) |
Production transfer costs (2) |
|
0.7 |
|
|
|
0.8 |
|
|
|
— |
|
|
|
1.5 |
|
|
|
— |
|
Acquisition-related costs (3) |
|
0.6 |
|
|
|
1.4 |
|
|
|
— |
|
|
|
2.0 |
|
|
|
— |
|
Other (4) |
|
— |
|
|
|
1.1 |
|
|
|
— |
|
|
|
1.1 |
|
|
|
— |
|
Non-GAAP gross profit |
$ |
79.7 |
|
|
$ |
74.7 |
|
|
$ |
72.7 |
|
|
$ |
154.4 |
|
|
$ |
127.1 |
|
Non-GAAP gross profit as % of revenues |
|
38.9 |
% |
|
|
38.0 |
% |
|
|
42.0 |
% |
|
|
38.5 |
% |
|
|
40.1 |
% |
Research and development expenses |
$ |
20.9 |
|
|
$ |
20.6 |
|
|
$ |
19.7 |
|
|
$ |
41.5 |
|
|
$ |
39.7 |
|
Stock-based compensation expense |
|
(1.4 |
) |
|
|
(1.5 |
) |
|
|
(1.8 |
) |
|
|
(2.9 |
) |
|
|
(3.5 |
) |
Intangibles amortization expense |
|
(2.1 |
) |
|
|
(2.1 |
) |
|
|
(1.6 |
) |
|
|
(4.2 |
) |
|
|
(3.2 |
) |
Acquisition-related costs (3) |
|
(0.1 |
) |
|
|
(0.3 |
) |
|
|
— |
|
|
|
(0.4 |
) |
|
|
— |
|
Other (4) |
|
(0.2 |
) |
|
|
— |
|
|
|
(0.1 |
) |
|
|
(0.2 |
) |
|
|
(0.1 |
) |
Non-GAAP research and development expenses |
$ |
17.1 |
|
|
$ |
16.7 |
|
|
$ |
16.2 |
|
|
$ |
33.8 |
|
|
$ |
32.9 |
|
Selling and administrative expenses |
$ |
43.0 |
|
|
$ |
43.5 |
|
|
$ |
36.5 |
|
|
$ |
86.5 |
|
|
$ |
70.3 |
|
Stock-based compensation expense |
|
(5.5 |
) |
|
|
(4.7 |
) |
|
|
(4.6 |
) |
|
|
(10.2 |
) |
|
|
(10.2 |
) |
Intangibles amortization expense |
|
(3.6 |
) |
|
|
(3.8 |
) |
|
|
(1.3 |
) |
|
|
(7.4 |
) |
|
|
(2.6 |
) |
Production transfer costs (2) |
|
(0.1 |
) |
|
|
— |
|
|
|
— |
|
|
|
(0.1 |
) |
|
|
— |
|
Acquisition-related costs (3) |
|
(1.3 |
) |
|
|
(2.5 |
) |
|
|
— |
|
|
|
(3.8 |
) |
|
|
— |
|
Other (4) |
|
(0.1 |
) |
|
|
(0.1 |
) |
|
|
(0.5 |
) |
|
|
(0.2 |
) |
|
|
(0.1 |
) |
Non-GAAP selling and administrative expenses |
$ |
32.4 |
|
|
$ |
32.4 |
|
|
$ |
30.1 |
|
|
$ |
64.8 |
|
|
$ |
57.4 |
|
Operating expenses |
$ |
313.2 |
|
|
$ |
65.6 |
|
|
$ |
56.8 |
|
|
$ |
378.8 |
|
|
$ |
111.6 |
|
Stock-based compensation expense |
|
(6.9 |
) |
|
|
(6.2 |
) |
|
|
(6.4 |
) |
|
|
(13.1 |
) |
|
|
(13.7 |
) |
Intangibles amortization expense |
|
(5.7 |
) |
|
|
(5.9 |
) |
|
|
(2.9 |
) |
|
|
(11.6 |
) |
|
|
(5.8 |
) |
Goodwill impairment |
|
(249.4 |
) |
|
|
— |
|
|
|
— |
|
|
|
(249.4 |
) |
|
|
— |
|
Restructuring charges |
|
0.1 |
|
|
|
(1.5 |
) |
|
|
(0.6 |
) |
|
|
(1.4 |
) |
|
|
(1.6 |
) |
Production transfer costs (2) |
|
(0.1 |
) |
|
|
— |
|
|
|
— |
|
|
|
(0.1 |
) |
|
|
— |
|
Acquisition-related costs (3) |
|
(1.4 |
) |
|
|
(2.8 |
) |
|
|
— |
|
|
|
(4.2 |
) |
|
|
— |
|
Other (4) |
|
(0.3 |
) |
|
|
(0.1 |
) |
|
|
(0.6 |
) |
|
|
(0.4 |
) |
|
|
(0.2 |
) |
Non-GAAP operating expenses |
$ |
49.5 |
|
|
$ |
49.1 |
|
|
$ |
46.3 |
|
|
$ |
98.6 |
|
|
$ |
90.3 |
|
Net (loss) earnings |
$ |
(259.3 |
) |
|
$ |
2.5 |
|
|
$ |
13.6 |
|
|
$ |
(256.8 |
) |
|
$ |
8.4 |
|
Interest expense, net |
|
4.6 |
|
|
|
4.4 |
|
|
|
0.8 |
|
|
|
9.0 |
|
|
|
1.6 |
|
Provision for income taxes |
|
18.8 |
|
|
|
3.2 |
|
|
|
3.8 |
|
|
|
22.0 |
|
|
|
4.9 |
|
(Loss) earnings before interest and income taxes |
|
(235.9 |
) |
|
|
10.1 |
|
|
|
18.2 |
|
|
|
(225.8 |
) |
|
|
14.9 |
|
(Loss) earnings before interest and income taxes as % of revenues |
|
(115.2 |
)% |
|
|
5.1 |
% |
|
|
10.5 |
% |
|
|
(56.3 |
)% |
|
|
4.7 |
% |
Stock-based compensation expense |
|
7.4 |
|
|
|
6.7 |
|
|
|
7.1 |
|
|
|
14.1 |
|
|
|
14.9 |
|
Intangibles amortization expense |
|
5.7 |
|
|
|
5.9 |
|
|
|
2.9 |
|
|
|
11.6 |
|
|
|
5.8 |
|
Goodwill impairment |
|
249.4 |
|
|
|
— |
|
|
|
— |
|
|
|
249.4 |
|
|
|
— |
|
Restructuring charges |
|
0.2 |
|
|
|
2.5 |
|
|
|
(1.1 |
) |
|
|
2.7 |
|
|
|
— |
|
Production transfer costs (2) |
|
0.8 |
|
|
|
0.8 |
|
|
|
— |
|
|
|
1.6 |
|
|
|
— |
|
Acquisition-related costs (3) |
|
2.0 |
|
|
|
4.2 |
|
|
|
— |
|
|
|
6.2 |
|
|
|
— |
|
Gain on sale of asset, net (5) |
|
— |
|
|
|
(5.4 |
) |
|
|
— |
|
|
|
(5.4 |
) |
|
|
— |
|
Other (4) |
|
(0.1 |
) |
|
|
0.9 |
|
|
|
0.6 |
|
|
|
0.8 |
|
|
|
0.2 |
|
Adjusted earnings before interest and income taxes |
$ |
29.5 |
|
|
$ |
25.7 |
|
|
$ |
27.7 |
|
|
$ |
55.2 |
|
|
$ |
35.8 |
|
Adjusted earnings before interest and income taxes as % of revenues |
|
14.4 |
% |
|
|
13.1 |
% |
|
|
16.0 |
% |
|
|
13.8 |
% |
|
|
11.3 |
% |
Net (loss) earnings |
$ |
(259.3 |
) |
|
$ |
2.5 |
|
|
$ |
13.6 |
|
|
$ |
(256.8 |
) |
|
$ |
8.4 |
|
Interest expense, net |
|
4.6 |
|
|
|
4.4 |
|
|
|
0.8 |
|
|
|
9.0 |
|
|
|
1.6 |
|
Provision for income taxes |
|
18.8 |
|
|
|
3.2 |
|
|
|
3.8 |
|
|
|
22.0 |
|
|
|
4.9 |
|
(Loss) earnings before interest and income taxes |
|
(235.9 |
) |
|
|
10.1 |
|
|
|
18.2 |
|
|
|
(225.8 |
) |
|
|
14.9 |
|
Non-GAAP reconciling adjustments (7) |
|
265.4 |
|
|
|
15.6 |
|
|
|
9.5 |
|
|
|
281.0 |
|
|
|
20.9 |
|
Depreciation expense |
|
7.7 |
|
|
|
8.1 |
|
|
|
8.2 |
|
|
|
15.8 |
|
|
|
17.4 |
|
Adjusted earnings before interest, income taxes, depreciation, and amortization ("Adjusted EBITDA") |
$ |
37.2 |
|
|
$ |
33.8 |
|
|
$ |
35.9 |
|
|
$ |
71.0 |
|
|
$ |
53.2 |
|
Adjusted EBITDA as a % of revenues |
|
18.2 |
% |
|
|
17.2 |
% |
|
|
20.8 |
% |
|
|
17.7 |
% |
|
|
16.8 |
% |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Quarter Ended |
|
Six Months Ended |
||||||||||||||||
|
June 30,
|
|
March 31,
|
|
June 30,
|
|
June 30,
|
|
June 30,
|
||||||||||
Provision for income taxes |
$ |
18.8 |
|
|
$ |
3.2 |
|
|
$ |
3.8 |
|
|
$ |
22.0 |
|
|
$ |
4.9 |
|
Income tax effects of non-GAAP reconciling adjustments (6) |
|
(16.4 |
) |
|
|
(0.5 |
) |
|
|
1.2 |
|
|
|
(16.9 |
) |
|
|
2.3 |
|
Non-GAAP provision for income taxes |
$ |
2.4 |
|
|
$ |
2.7 |
|
|
$ |
5.0 |
|
|
$ |
5.1 |
|
|
$ |
7.2 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net (loss) earnings |
$ |
(259.3 |
) |
|
$ |
2.5 |
|
|
$ |
13.6 |
|
|
$ |
(256.8 |
) |
|
$ |
8.4 |
|
Non-GAAP reconciling adjustments (7) |
|
265.4 |
|
|
|
15.6 |
|
|
|
9.5 |
|
|
|
281.0 |
|
|
|
20.9 |
|
Income tax effects of non-GAAP reconciling adjustments (6) |
|
(16.4 |
) |
|
|
(0.5 |
) |
|
|
1.2 |
|
|
|
(16.9 |
) |
|
|
2.3 |
|
Non-GAAP net earnings |
$ |
22.5 |
|
|
$ |
18.6 |
|
|
$ |
21.9 |
|
|
$ |
41.1 |
|
|
$ |
27.0 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Diluted (loss) earnings per share |
$ |
(2.90 |
) |
|
$ |
0.03 |
|
|
$ |
0.15 |
|
|
$ |
(2.87 |
) |
|
$ |
0.09 |
|
Earnings per share non-GAAP reconciling adjustment (6)(7) |
|
3.14 |
|
|
|
0.17 |
|
|
|
0.08 |
|
|
|
3.31 |
|
|
|
0.19 |
|
Non-GAAP diluted earnings per share |
$ |
0.24 |
|
|
$ |
0.20 |
|
|
$ |
0.23 |
|
|
$ |
0.44 |
|
|
$ |
0.28 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Diluted average shares outstanding |
|
89.4 |
|
|
|
90.5 |
|
|
|
91.8 |
|
|
|
89.5 |
|
|
|
92.1 |
|
Non-GAAP adjustment (8) |
|
3.8 |
|
|
|
2.2 |
|
|
|
3.1 |
|
|
|
3.5 |
|
|
|
2.7 |
|
Non-GAAP diluted average shares outstanding (8) |
|
93.2 |
|
|
|
92.7 |
|
|
|
94.9 |
|
|
|
93.0 |
|
|
|
94.8 |
|
Notes: | ||
(1) |
In addition to the GAAP financial measures included herein, Knowles has presented certain non-GAAP financial measures that exclude certain amounts that are included in the most directly comparable GAAP measures. Knowles believes that non-GAAP measures are useful as supplements to its GAAP results of operations to evaluate certain aspects of its operations and financial performance, and its management team primarily focuses on non-GAAP items in evaluating Knowles' performance for business planning purposes. Knowles also believes that these measures assist it with comparing its performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in Knowles' opinion, do not reflect its core operating performance. Knowles believes that its presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that Knowles uses internally for purposes of assessing its core operating performance. |
|
(2) |
Production transfer costs represent duplicate costs incurred to migrate manufacturing to facilities primarily within |
|
(3) |
These expenses are related to the acquisition of Cornell Dubilier by the Precision Devices segment. These expenses include ongoing costs to facilitate integration, the amortization of fair value adjustments to inventory, and costs incurred by the Company to carry out this transaction. |
|
(4) |
Other expenses include non-recurring professional service fees related to the execution of various reorganization projects, foreign currency exchange rate impacts on restructuring balances, and the ongoing net lease cost (income) related to facilities not used in operations. |
|
(5) |
This gain is related to the sale of intellectual property previously used in the Intelligent Audio product line, which is included within the Consumers MEMS Microphones segment. |
|
(6) |
Income tax effects of non-GAAP reconciling adjustments are calculated using the applicable tax rates in the jurisdictions of the underlying adjustments. |
|
(7) |
The non-GAAP reconciling adjustments are those adjustments made to reconcile (Loss) earnings before interest and income taxes to Adjusted earnings before interest and income taxes. |
|
(8) |
The number of shares used in the diluted per share calculations on a non-GAAP basis excludes the impact of stock-based compensation expense expected to be incurred in future periods and not yet recognized in the financial statements, which would otherwise be assumed to be used to repurchase shares under the GAAP treasury stock method. |
KNOWLES CORPORATION |
|||||||
CONSOLIDATED BALANCE SHEETS |
|||||||
(in millions, except share and per share amounts) |
|||||||
(unaudited) |
|||||||
|
June 30, 2024 |
|
December 31, 2023 |
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
84.0 |
|
|
$ |
87.3 |
|
Receivables, net of allowances of |
|
136.1 |
|
|
|
135.3 |
|
Inventories, net |
|
190.1 |
|
|
|
196.4 |
|
Prepaid and other current assets |
|
12.7 |
|
|
|
9.8 |
|
Total current assets |
|
422.9 |
|
|
|
428.8 |
|
Property, plant, and equipment, net |
|
159.4 |
|
|
|
175.4 |
|
Goodwill |
|
291.2 |
|
|
|
540.7 |
|
Intangible assets, net |
|
177.3 |
|
|
|
189.4 |
|
Operating lease right-of-use assets |
|
10.6 |
|
|
|
13.1 |
|
Other assets and deferred charges |
|
116.7 |
|
|
|
115.4 |
|
Total assets |
$ |
1,178.1 |
|
|
$ |
1,462.8 |
|
|
|
|
|
||||
Current liabilities: |
|
|
|
||||
Current maturities of long-term debt |
$ |
48.8 |
|
|
$ |
47.1 |
|
Accounts payable |
|
52.5 |
|
|
|
51.3 |
|
Accrued compensation and employee benefits |
|
32.2 |
|
|
|
33.0 |
|
Operating lease liabilities |
|
4.1 |
|
|
|
5.1 |
|
Other accrued expenses |
|
22.0 |
|
|
|
25.0 |
|
Federal and other taxes on income |
|
19.3 |
|
|
|
3.1 |
|
Total current liabilities |
|
178.9 |
|
|
|
164.6 |
|
Long-term debt |
|
212.4 |
|
|
|
224.1 |
|
Deferred income taxes |
|
0.8 |
|
|
|
0.7 |
|
Long-term operating lease liabilities |
|
6.9 |
|
|
|
8.2 |
|
Other liabilities |
|
26.1 |
|
|
|
31.1 |
|
Commitments and contingencies |
|
|
|
||||
Stockholders' equity: |
|
|
|
||||
Preferred stock - |
|
— |
|
|
|
— |
|
Common stock - |
|
1.0 |
|
|
|
1.0 |
|
Treasury stock - at cost; 9,637,821 and 8,204,832 shares at June 30, 2024 and December 31, 2023, respectively |
|
(176.3 |
) |
|
|
(151.2 |
) |
Additional paid-in capital |
|
1,698.3 |
|
|
|
1,689.9 |
|
Accumulated deficit |
|
(632.6 |
) |
|
|
(375.8 |
) |
Accumulated other comprehensive loss |
|
(137.4 |
) |
|
|
(129.8 |
) |
Total stockholders' equity |
|
753.0 |
|
|
|
1,034.1 |
|
Total liabilities and stockholders' equity |
$ |
1,178.1 |
|
|
$ |
1,462.8 |
|
KNOWLES CORPORATION |
|||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
(in millions) |
|||||||
(unaudited) |
|||||||
|
|
||||||
|
Six Months Ended June 30, |
||||||
|
2024 |
|
2023 |
||||
Operating Activities |
|
|
|
||||
Net (loss) earnings |
$ |
(256.8 |
) |
|
$ |
8.4 |
|
Adjustments to reconcile net (loss) earnings to cash from operating activities: |
|||||||
Goodwill impairment |
|
249.4 |
|
|
|
— |
|
Depreciation and amortization |
|
27.4 |
|
|
|
23.2 |
|
Stock-based compensation |
|
14.1 |
|
|
|
14.9 |
|
Deferred income taxes |
|
0.9 |
|
|
|
3.7 |
|
Non-cash interest expense and amortization of debt issuance costs |
|
4.3 |
|
|
|
0.4 |
|
Gain on sale of fixed assets |
|
(1.1 |
) |
|
|
(4.8 |
) |
Gain on sale of asset |
|
(7.2 |
) |
|
|
— |
|
Non-cash restructuring charges |
|
0.4 |
|
|
|
(1.7 |
) |
Other, net |
|
(0.4 |
) |
|
|
(2.8 |
) |
Changes in assets and liabilities (excluding effects of foreign exchange): |
|
|
|
||||
Receivables, net |
|
(1.0 |
) |
|
|
16.9 |
|
Inventories, net |
|
3.4 |
|
|
|
(26.8 |
) |
Prepaid and other current assets |
|
(2.4 |
) |
|
|
(2.4 |
) |
Accounts payable |
|
2.8 |
|
|
|
7.3 |
|
Accrued compensation and employee benefits |
|
(0.6 |
) |
|
|
(2.7 |
) |
Other accrued expenses |
|
(2.6 |
) |
|
|
0.5 |
|
Accrued taxes |
|
17.2 |
|
|
|
(2.6 |
) |
Other non-current assets and non-current liabilities |
|
(5.6 |
) |
|
|
(9.1 |
) |
Net cash provided by operating activities |
|
42.2 |
|
|
|
22.4 |
|
|
|
|
|
||||
Investing Activities |
|
|
|
||||
Proceeds from the sale of property, plant, and equipment |
|
— |
|
|
|
12.1 |
|
Proceeds from the sale of asset |
|
7.2 |
|
|
|
— |
|
Capital expenditures |
|
(6.6 |
) |
|
|
(7.9 |
) |
Purchase of investments |
|
(0.5 |
) |
|
|
(0.4 |
) |
Proceeds from the sale of investments |
|
0.5 |
|
|
|
0.4 |
|
Net cash provided by investing activities |
|
0.6 |
|
|
|
4.2 |
|
|
|
|
|
||||
Financing Activities |
|
|
|
||||
Payments under revolving credit facility |
|
(92.0 |
) |
|
|
— |
|
Borrowings under revolving credit facility |
|
78.0 |
|
|
|
— |
|
Repurchase of common stock |
|
(25.0 |
) |
|
|
(12.5 |
) |
Tax on restricted and performance stock unit vesting and stock option exercises |
|
(5.9 |
) |
|
|
(6.1 |
) |
Payments of debt issuance costs |
|
— |
|
|
|
(1.9 |
) |
Payments of finance lease obligations |
|
(1.3 |
) |
|
|
(1.2 |
) |
Proceeds from exercise of stock options |
|
0.2 |
|
|
|
1.6 |
|
Net cash used in financing activities |
|
(46.0 |
) |
|
|
(20.1 |
) |
|
|
|
|
||||
Effect of exchange rate changes on cash and cash equivalents |
|
(0.1 |
) |
|
|
(0.3 |
) |
|
|
|
|
||||
Net (decrease) increase in cash and cash equivalents |
|
(3.3 |
) |
|
|
6.2 |
|
Cash and cash equivalents at beginning of period |
|
87.3 |
|
|
|
48.2 |
|
Cash and cash equivalents at end of period |
$ |
84.0 |
|
|
$ |
54.4 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731995805/en/
Sarah Cook
Knowles Investor Relations
Email: investorrelations@knowles.com
Source: Knowles Corporation
FAQ
What was Knowles 's (KN) revenue for Q2 2024?
How much net cash from operations did Knowles (KN) generate in Q2 2024?
What was Knowles' (KN) non-GAAP diluted earnings per share for Q2 2024?
What segments does Knowles (KN) expect to see growth in for Q3 2024?